Accelerates Fat Burning: Thermogenic compounds increase calorie burn, even at rest, helping to melt away stubborn belly fat. Suppresses Appetite: Reduces hunger and emotional eating—the main culprits ...

Haverhill contributed €14 million in net sales and €3 million in Core EBITDA in H1 2025 consolidated results, compared to €25 million in net sales and €9 million in Core EBITDA in H1 2024, and €35 ...

Paris, France (29 July 2025 – 6:30 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2025 to approve the condensed consolidated interim financial statements for the six-month period ...

Toronto, ON, July 29, 2025 (GLOBE NEWSWIRE) -- As wildfires continue to impact communities across Saskatchewan, LifeLabs is pleased to deepen its commitment to relief efforts, contributing an ...

Paris, France (29 juillet 2025 – 18h30) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2025, a arrêté les comptes consolidés résumés du premier semestre 2025.

Hapbee Technologies Inc. is publicly traded on the TSX Venture Exchange under the symbol HAPB and is also available to U.S. investors via the OTC Markets under the symbol HAPBF. For those interested ...

Une conférence téléphonique dédiée aux analystes et organisée par la direction d’EUROAPI se tiendra demain, le mercredi 30 juillet 2025, à 8h30 CET, lors d’un webcast audio (en direct et en replay).

LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community – – ...

As of June 30, 2025, the Company had cash, cash equivalents and investment securities of $377.0 million. The Company expects that cash, cash equivalents and investment securities will be sufficient to ...

FREIBURG, Germany, July 29, 2025 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in active implantable medical technologies, today announced the first human implantation of its proprietary BCI system, ...

The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S. expansion, where over 430,000 IVF cycles took place in 2023 BANGKOK, July 29, 2025 (GLOBE NEWSWIRE) -- ...

Research & Development: Sartorius Stedim Biotech will collaborate with Bio Usawa to develop state-of-the-art biosimilar cell lines tailored to therapeutic needs in Africa.